Live
CellBringing the genetically minimal cell to life on a computer in 4DIlluminaCanaccord cuts Illumina stock price target on competition concerns - Investing.comEndpoints NewsSeaport, Hemab price IPOs, while Avalyn soars in Nasdaq debutThermo FisherIs Thermo Fisher’s New U.S. Bioprocess Design Center Shaping a Deeper Biopharma Strategy for TMO? - simplywall.stEndpoints NewsJ&J axes pair of CAR-T therapies for lymphoma, citing evolving marketEndpoints NewsBoehringer appoints pharma veteran for corporate affairs post; BlueRock CSO heads for the exitNovo NordiskA proposal seeks to remove Novo and Lilly drugs from key list in the US – will provide better protection against copies - medwatch.comFierceBiotechAmgen abandons candidates for cancer, Sjögren’s syndrome over weak ph. 2 dataAmgenAmgen abandons candidates for cancer, Sjögren’s syndrome over weak ph. 2 data - Fierce BiotechSamsung Biologics(LEAD) Samsung Biologics union launches 1st general strike over pay dispute - Yonhap News AgencySamsung BiologicsSamsung Biologics, Lilly to Launch Biotech Hub Supporting Venture Ecosystem - Seoul Economic DailyBioPharma DiveTwo biotechs raise a combined $556M in latest spurt of IPOs
Recursion 30. Apr. 2026

Recursion Announces Board Transition - The Manila Times

Recursion Announces Board Transition - The Manila Times

Original
Inhalt nicht verfügbar. Bitte die Originalquelle aufrufen.